Opening the Conversation

• Tell me about the timeline that led you to seek reproductive care, from first concern to the referral you received.
• When did you receive any formal diagnosis or decide to pursue egg freezing or fertility treatment? Options: Within the last month, 1 to 3 months ago, 3 to 12 months ago, More than 12 months ago
• Describe any prior treatments, monitoring, or self-directed attempts you or your partner have tried and the outcomes.
• How many prior diagnostic tests or specialist consults have you completed, and which of those felt most informative?
• Who will be the primary decision maker about moving forward, and who else must approve or be informed? Options: The patient alone, Patient and partner jointly, Patient plus family decision, Employer benefits manager involved, Referring clinician has final say, Other
• Which of these roles will you want involved in our first care plan conversation? Options: Patient, Partner, Referring OB/GYN, Primary care provider, Employer benefits manager, Other
• Will you be able to commit to an initial consultation within two weeks if we can confirm insurance eligibility or a clear next step? Options: Yes, Maybe with conditions, No

Where the Medical Story Really Begins

• If you continued only with your current care, what is the most likely clinical outcome for fertility in the next 12 months?
• How has age, ovarian reserve, or partner factors changed the urgency of starting an assisted reproductive protocol for you?
• What single medical or lifestyle factor do you think has most limited your chances so far?
• Which areas of your history should we prioritize because records are missing or unclear? Options: Recent semen analysis, AMH or ovarian reserve testing, Uterine imaging such as HSG or sonohysterogram, Prior IVF/IVF cycle summary, Genetic carrier screening, Medication or treatment history
• If you could guarantee one change from a new care path, which single change would make you sign up this week?

The Referral and Prior Diagnostics

• Name any gaps in the prior workup that would require us to repeat or add tests before we schedule treatment.
• List the specific diagnostic reports you can share now and the dates they were performed.
• Select the reports you have available to upload today. Options: Semen analysis, HSG or sonohysterogram, AMH and FSH labs, Prior IVF cycle summary, Genetic carrier screening, None available
• How complete were the referring clinician's notes in describing prior treatments and any recommended next steps? Options: Very complete, Mostly complete, Somewhat incomplete, Missing
• Would you be willing to pause scheduling until we complete any missing key tests identified in the workup? Options: Yes, pause until complete, Proceed while completing tests, Depends on which test, No, do not pause

Goals that Matter, Not the Checklist

• What result would make this entire process feel like a success for you and your partner?
• Rank the following goals in order of importance to you. Options: Live birth with single embryo transfer, Shortest possible timeline to pregnancy, Minimize medication intensity, Preserve future fertility (egg freezing), Genetic testing to reduce risk of inherited conditions
• Choose the time horizon that would meet your primary goal. Options: Within 3 months, 3 to 6 months, 6 to 12 months, Longer than 12 months, Unsure
• Tell me how the possibility of delay or failed cycles affects your willingness to continue treatment emotionally and practically.
• Would you proceed if achieving your primary goal required a more intensive protocol with higher medication doses? Options: Yes, Maybe, need more info, No

Who Signs Off and Who's On Call

• Who else will need to sign off before we can begin treatment, including payers, partners, or clinicians?
• List any legal, guardianship, or payer arrangements that affect consent or payment.
• Select which payment or authorization stakeholders you have already contacted. Options: Primary insurer, Secondary insurer, Employer benefits manager, Private pay counselor, Family member paying, No one contacted yet
• Describe any religious, cultural, or personal constraints that would influence protocol choices or the use of donor material.
• Is there any person, policy, or payer that could veto treatment even if you and your partner approve? Options: Yes, No, Unsure

Risks, Fears, and What Keeps You Up at Night

• Where do you feel most vulnerable about pursuing assisted reproductive treatment right now?
• Share how any prior negative experiences with reproductive care have shaped your trust and expectations of a new clinic.
• Choose the fears that matter most to you. Options: Cycle failure and financial loss, Medication side effects, Procedural or surgical risks, Multiple pregnancy, Emotional toll and burnout, Privacy of records
• Name the one risk that, if eliminated, would most increase your readiness to move forward.
• Do you want access to a dedicated counselor or peer support during treatment cycles? Options: Yes, counseling, Peer support group, Both, No

The Other Paths You're Considering

• Start by listing the other clinics, internal programs, or do-it-yourself options you are seriously considering and why each appeals to you.
• For each alternative, name the single strength that makes it feel attractive compared with starting with us.
• Choose the reason that would most likely keep you with your current provider instead of switching. Options: Cost, Established trust, Convenience or location, Insurance coverage, Preference for their protocol, No clear reason to change
• Has anyone on your care team proposed solving this internally rather than referring to an outside clinic? Options: Yes, proposed internal solution, No, referral only, Unsure
• At this point, is there a preferred path that would close the conversation for you and remove the need for further proposals? Options: Yes, staying with current plan, Yes, another provider, No, still open, Unsure

Practical Readiness and Constraints

• Identify any technical, coverage, or compliance requirements that would block starting care within 30 days.
• Mark which of these items are already completed and current for your case. Options: Insurance eligibility verified, Pre-authorization obtained, Recent labs within 60 days, Medical clearance from other specialists, Donor or partner screening complete, None of the above
• Please indicate who can release prior medical records or diagnostic files and confirm they can authorize uploads. Options: Patient, Referring clinician, Medical records office, Partner, Other
• Name the systems or portals we would need to access or integrate with to retrieve past data or confirm benefits.
• Are there legal, employer, or regulatory approvals that could veto or significantly delay treatment? Options: Yes, No, Unsure

Next Steps and Mutual Commitments

• Imagine we removed your biggest barrier, what single action would you expect us to take next to get you started?
• Pick how soon you want a detailed care plan and a full financial review. Options: Within 1 week, 1 to 2 weeks, 3 to 4 weeks, Unsure
• Please name the primary owner on your side for scheduling and the best contact details for day-to-day coordination.
• Are you willing to prioritize a suggested diagnostic within seven days if it would unblock timely treatment? Options: Yes, Maybe, need details, No
• Assuming the plan meets your clinical aim and coverage looks favorable, will you be prepared to schedule the first procedure within 14 days? Options: Yes, schedule within 14 days, Need more time or approvals, No

• Treatment Options & Expected Outcomes

• Confirm the current state and what it is costing you
• You confirm the demonstrated pathway comparison eliminates the uncertainty you described and clarifies the trade-offs between success probability, cost, and timeline.
• Deliver a personalized treatment comparison worksheet with modeled success rates, timelines, and projected out-of-pocket cost ranges within 3 business days.
• You accept the success-rate and timeline assumptions used for your case or identify specific adjustments needed for re-modeling.
• Walk through personalized treatment pathways
• Prepare a draft set of measurable outcome metrics and monitoring cadence tied to the selected pathway for review at the care plan finalization session.
• You agree to proceed to care plan and scope finalization, and identify the remaining evidence required by decision-makers.
• Prove comparative success-rate and cost context
• Provide the latest clinical data to be modeled, including AMH, antral follicle count, semen analysis, prior cycle summaries, and any referral notes, within 2 business days.
• Review risks, side effects, and mitigation aligned to your constraints
• Identify the decision-makers, their top priorities, and any coverage constraints to be included in the care plan finalization meeting.
• Validate that this matches your priorities and reduces uncertainty

• Treatment Options & Expected Outcomes, Solution Experience
• Solution Experience Deck - Treatment Options & Expected Outcomes
• Treatment Options & Expected Outcomes Brief

• meeting
• slides
• document

• Ovarian Stimulation Medication Management
• Transvaginal Oocyte Retrieval under Sedation
• In-Vitro Fertilization (IVF) Cycle Laboratory Services
• Intracytoplasmic Sperm Injection (ICSI)
• Blastocyst Culture and Embryo Grading
• Embryo Vitrification and Cryostorage
• Frozen Embryo Transfer (FET) Cycle Management
• Intrauterine Insemination (IUI) Procedure
• Preimplantation Genetic Testing (PGT-A/PGT-M)
• Sperm Processing and Semen Cryopreservation
• Single-Embryo Transfer Protocol Implementation
• Early Pregnancy Monitoring and Support
• Egg Freezing (Oocyte Cryopreservation)
• Financial Counseling and Insurance Benefits Coordination

Ovarian Stimulation Medication Management

• Which stimulation protocol do you intend to use for this cycle (gonadotropin antagonist, long agonist, micro-dose flare, natural)? Options: Gonadotropin antagonist, Long GnRH agonist, Micro-dose flare, Natural cycle, Other
• What starting gonadotropin dose (IU/day) and anticipated dose-adjustment rules should we plan in the protocol?
• Who will be authorized to place and change medication orders in the clinic record for this patient? Options: Reproductive endocrinologist, Advanced practice provider, Designated clinic RN, Other
• When should baseline monitoring (transvaginal ultrasound and serum estradiol) be scheduled relative to cycle day? Options: Cycle day 2, Cycle day 3, Other
• Have you had prior cycles complicated by ovarian hyperstimulation syndrome (OHSS) that require a tailored trigger or antagonist strategy? Options: Yes, No
• How will you document medication administration and patient self-injection training (medication log, video, in-clinic demonstration)? Options: Medication log, In-clinic demonstration note, Video confirmation, Other

Transvaginal Oocyte Retrieval under Sedation

• Which level of sedation do you require for retrievals in this case (conscious sedation, monitored anesthesia care, general anesthesia)? Options: Conscious sedation, Monitored anesthesia care (MAC), General anesthesia
• What ASA (American Society of Anesthesiologists) classification cutoff and pre-op clearance rules apply to proceed with retrieval? Options: ASA I-II, ASA III with anesthesia clearance, Custom / Discuss
• Who must complete and sign the procedure consent form and which specific consent items are required (procedural risks, potential need for conversion to general anesthesia, specimen handling)?
• When should the patient be instructed to be NPO (nothing by mouth) before retrieval and what medications may be permitted with a sip of water? Options: NPO 6 hours, NPO 8 hours, Other
• How should peri-procedural sedation and PACU discharge criteria be recorded in the shared chart (anesthesia record template, PACU checklist)? Options: Anesthesia record template, PACU checklist, Both

In-Vitro Fertilization (IVF) Cycle Laboratory Services

• Which witness and chain-of-custody procedure do you require for gamete and embryo handling (two-person manual witness, electronic witness tracking, hybrid)? Options: Two-person manual witness, Electronic witness tracking, Hybrid
• What laboratory performance thresholds should be applied for this case (target fertilization rate, cleavage rate, blastulation rate)?
• Who will be the assigned embryology lead for this case or how should embryology assignments be communicated to your care team?
• When do you require key lab timepoints to be posted to the shared record (fertilization check at ~16-18 hours, cleavage check day 2-3, blastocyst report day 5-6)? Options: Within 24 hours of check, Within 48 hours, Custom
• What objective acceptance criteria will confirm laboratory services are complete and acceptable for proceeding (documented fertilization count, embryo grades per day, signed witness logs)?

Intracytoplasmic Sperm Injection (ICSI)

• Which clinical indications for ICSI apply to this cycle (severe male factor, prior fertilization failure, requirement for PGT)? Options: Severe male factor, Prior fertilization failure, PGT requirement, Other
• What specific semen parameters (concentration, progressive motility, morphology) would trigger ICSI rather than conventional insemination?
• Who will supply the sperm source and the sperm procurement method (partner fresh sample, surgically retrieved, donor sample)? Options: Partner - fresh, Partner - surgically retrieved, Donor
• When in the laboratory timeline do you require ICSI to be performed relative to oocyte retrieval (number of hours post-retrieval)? Options: Within 4 hours, 4-6 hours, Other
• Are there specialized micromanipulation techniques required for this case (assisted oocyte activation, calcium ionophore) that must be documented in the protocol? Options: Yes, No

Blastocyst Culture and Embryo Grading

• Which culture duration will you require for embryos in this cycle (day 3 transfer, extended culture to day 5/6 blastocyst)? Options: Day 3 transfer, Day 5 blastocyst, Day 6 blastocyst/extended, Case-by-case
• What embryo grading system must be recorded in the chart (Gardner blastocyst grading, day-specific morphology descriptors)? Options: Gardner grading, Day-specific cleavage descriptors, Other
• Who will approve extended culture to blastocyst when embryo numbers are limited (attending physician, lab director, standing protocol)? Options: Attending physician, Lab director, Standing protocol
• When should embryo morphology images and grading annotations be uploaded to the shared patient record (day 3, day 5, other)? Options: Day 3, Day 5, Both, Other
• How will you define the minimum blastocyst quality acceptable for transfer versus cryopreservation (specific grade thresholds or embryo competency metrics)?

Embryo Vitrification and Cryostorage

• Which signed documents must be in place before vitrification (vitrification consent, cryostorage agreement with disposition options)?
• What initial cryostorage duration and renewal cadence do you require (1 year, 3 years, 5 years, auto-renew)? Options: 1 year, 3 years, 5 years, Auto-renew / Custom
• Who will be the authorized contacts for emergency specimen access or transfer from storage and what identification is required?
• When should cryostorage environmental and alarm logs be shared with your team (daily, weekly summary, on-incident only)? Options: Daily, Weekly summary, On incident only
• What evidence will validate successful vitrification and storage acceptance (cryostorage certificate, witness signature, temperature-log reconciliation)?

Frozen Embryo Transfer (FET) Cycle Management

• Which endometrial preparation strategy do you prefer for FET in this case (true natural cycle, modified natural, hormonally prepared with estradiol and progesterone)? Options: True natural, Modified natural, Hormonally prepared
• What endometrial thickness threshold on ultrasound will you accept prior to initiating progesterone or scheduling transfer? Options: >=7 mm, >=8 mm, Custom
• Who will own timing decisions for progesterone start relative to transfer (patient with instruction, clinic nurse call, physician order)? Options: Patient with instruction, Clinic nurse, Physician order
• When do you want post-transfer testing scheduled (timing for serum beta-hCG and confirmatory testing)? Options: Beta at 9-11 days post-transfer, Beta at 12-14 days, Custom
• How should embryo warming survivability be documented prior to transfer (post-warm survival count, embryo appearance notes in the lab report)?

Intrauterine Insemination (IUI) Procedure

• Which indication(s) apply for IUI in this case (unexplained infertility, oligo-ovulation, donor sperm)? Options: Unexplained infertility, Oligo-ovulation, Donor sperm, Other
• What semen processing method should be used for IUI (density gradient centrifugation, swim-up, other)? Options: Density gradient, Swim-up, Other
• Who will be responsible for sample collection, labeling, and chain-of-custody for the IUI specimen? Options: Patient at clinic, Partner at clinic, Off-site with transport
• When must post-wash sperm concentration and progressive motility be reported to the care team prior to insemination? Options: Within 2 hours, Same day, Other
• Are there procedural or positioning preferences during insemination you require documented in the case note? Options: Yes, No

Preimplantation Genetic Testing (PGT-A/PGT-M)

• Which PGT test is requested for this patient (PGT-A for aneuploidy screening, PGT-M for monogenic disease), and which specific gene/panel if PGT-M? Options: PGT-A, PGT-M - specify gene/panel
• What genetic counseling documentation and signed informed consent must accompany the PGT requisition?
• Who will coordinate biopsy-to-lab logistics and provide the required lab requisition and sample ID forms? Options: Clinic lab coordinator, External courier, Other
• When must biopsy samples be shipped to the genetic testing lab relative to biopsy time and under what packaging/temperature conditions?
• What acceptance criteria will validate PGT reporting for this case (signed lab report, matched sample IDs, variant/aneuploidy interpretation documented)?

Sperm Processing and Semen Cryopreservation

• Which processing services do you require for sperm in this cycle (processing for IUI, preparation for IVF/ICSI, cryopreservation for future use)? Options: IUI processing, IVF/ICSI preparation, Cryopreservation
• What post-process thresholds must be reported (post-wash concentration, total motile count, percent progressive motility)?
• Who must sign the semen cryopreservation consent and what disposition instructions should be recorded (duration, disposition on death, transfer options)?
• When should post-thaw quality checks be performed and how should results be reported if the sample will be used for a cycle? Options: At scheduled thaw, Within 24 hours of planned use, Other
• Are there special transport or cross-border regulatory requirements for donor or partner semen that we should plan for? Options: Yes, No

Single-Embryo Transfer Protocol Implementation

• Which single-embryo transfer (SET) policy will apply with respect to patient age and embryo stage for this case?
• What documented exceptions to SET will you allow (patient request after counseling, poor embryo quality) and how must those exceptions be recorded?
• Who is authorized to approve deviations from the SET policy and what signature or waiver is required from the patient? Options: Attending physician, Patient signed waiver, Other
• When should counseling about multiple pregnancy risks and benefits of SET be completed and documented (pre-transfer visit, at consent signing)? Options: Pre-transfer visit, At consent signing, Other
• How will SET adherence and outcomes be tracked for audit purposes (monthly compliance report, case review log)? Options: Monthly compliance report, Quarterly case review, Ad-hoc

Early Pregnancy Monitoring and Support

• Which post-transfer monitoring schedule do you require for serum beta-hCG and first transvaginal ultrasound? Options: Beta 9-11 days, TVUS 6-7 weeks, Beta 12-14 days, TVUS per clinical judgment, Custom
• What beta-hCG rise or absolute thresholds and serum progesterone cutoffs will trigger repeat testing or early intervention?
• Who provides early pregnancy counseling and what escalation contact should patients use for suspected complications (bleeding, severe pain)?
• When should suspected ectopic pregnancy or non-viable pregnancy be escalated to on-call physician based on ultrasound or beta trends? Options: Abnormal beta trends, Suspicious ultrasound, Both

• Informed Consent for Treatment
• Care Plan & Services Agreement (SOW)
• Insurance Verification & Pre-Authorization Consent
• Financial Responsibility & Payment Agreement
• Assignment of Benefits and Payment Authorization
• Medical Records Release & Referral Authorization
• Genetic Testing & Laboratory Consent
• Pre-Authorization Denial & Financial Contingency Agreement
• Notice of Privacy Practices Acknowledgement
• HIPAA Business Associate Addendum (BAA) — Conditional

• Early Post-Cycle Health Check (weeks 1-4)
• First Outcome Review (weeks 4-10)
• Acceptance Gate Review (around day 90)
• Ongoing Recovery and Outcome Monitoring (quarterly, up to 12 months)

• Respond to outstanding enhancement requests with a status update and proposed next steps in the shared channel.
• Log any unresolved insurance or billing impacts affecting follow-up and set resolution target dates.
• Restate acceptance criteria and numeric targets
• Produce a documented pass/fail result for each acceptance criterion recorded in Care Plan & Scope.
• For any failed criteria, agree remediation actions with completion dates and a re-evaluation plan.
• Publish a concise acceptance summary to the shared outcome channel within 48 hours.
• Publish the acceptance gate report with pass/fail outcomes and remediation plans to the shared channel.
• Open remediation workstreams for each failed criterion with target resolution dates.
• Schedule a re-check meeting or data review aligned to remediation timelines if any criteria failed.
• Review cumulative outcomes since last review
• Confirm cumulative realization of key outcomes (live birth rate per cycle, patient satisfaction score) relative to Care Plan & Scope targets.
• Identify and schedule resolution for any persistent issues impacting outcomes or patient experience.
• Keep the enhancement and issue backlog current and assign realistic timelines for outstanding items.
• Update clinical records and outcome registries with final outcome status for each case reviewed.
• Move persistent issues into a prioritized improvement backlog and document expected completion quarters.
• Re-confirm Care Plan & Scope commitments
• Confirm the cycle completed according to the Care Plan & Scope and that lab and procedure records are available.
• Identify any immediate clinical or operational blockers and agree next actions to remediate within 7 days.
• Ensure the shared outcome channel is active for case updates and issue reporting.
• Document and distribute the early clinical findings and any deviations from the Care Plan within 24 hours.
• Order or schedule any immediate follow-up tests or clinician checks identified during the session.
• Open operational tickets for insurance, billing, or lab record gaps and log expected resolution dates.
• Present first outcome data vs Care Plan & Scope targets
• Confirm whether first-measure outcomes (positive pregnancy test rate per cycle, clinical pregnancy rate at 6-8 weeks) are trending toward the targets recorded in Care Plan & Scope.
• Name specific root causes for any shortfalls and agree corrective actions with dates for remediation before the acceptance gate.
• Confirm timeline and data needed for the Acceptance Gate Review around day 90.
• Publish the first-outcome dashboard extract and gap analysis to the shared channel.
• Initiate agreed clinical adjustments or diagnostics and record expected completion dates.
• Present outcome data against each acceptance criterion
• Surface persistent clinical or operational issues
• Confirm procedural and specimen completion
• Diagnose gaps and root causes
• Document pass/fail and discuss conditional acceptances
• Review early clinical signals and symptoms
• Review shared channel items and enhancement requests
• Patient experience and adverse events review
• Operational blockers and coverage issues
• Agree corrective actions and timeline to acceptance gate
• Agree next actions and monitoring cadence
• If needed, agree remediation plan and resolution timeline
• Shared channel and communication confirmation
• Record acceptance decision and next steps
• Short-form check when no changes